E R Schwarz

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. ncbi request reprint A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both?
    Ernst R Schwarz
    Division of Cardiology, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Cardiovasc Pharmacol Ther 11:232-44. 2006
  2. pmc Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy
    R P Morrissey
    Division of Cardiology, Department of Medicine, Cedars Sinai Medical Centre and David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    Cardiovasc J Afr 22:38-44. 2011
  3. pmc The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
    Jeremy A Falk
    Cedars Sinai Women s Guild Lung Institute, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Vasc Health Risk Manag 6:273-80. 2010
  4. pmc Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men
    Ernst R Schwarz
    Cenegenics Education and Research Foundation, Las Vegas and Heart Institute of Southern California, Beverly Hills, 348 S Oakhurst Dr, Beverly Hills, CA 90212, USA
    J Geriatr Cardiol 8:201-6. 2011
  5. pmc Andropause and the development of cardiovascular disease presentation-more than an epi-phenomenon
    Ernst R Schwarz
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Suite 6215, Los Angeles, CA 90048, USA Cenegenics Medical Institute, 851 Rampart Blvd, Las Vegas, NV 89145, USA
    J Geriatr Cardiol 8:35-43. 2011
  6. doi request reprint Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension
    Dioma U Udeoji
    Heart Institute of Southern California, Beverly Hills, Los Angeles, CA, USA
    Ther Adv Respir Dis 7:39-49. 2013
  7. doi request reprint Pilot study of palliative care consultation in patients with advanced heart failure referred for cardiac transplantation
    Ernst R Schwarz
    Cedars Sinai Heart Institute and Palliative Care Program, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Palliat Med 15:12-5. 2012
  8. pmc The clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure
    E R Schwarz
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center and University of California Los Angeles UCLA, Los Angeles, California, USA
    Cardiovasc J Afr 21:212-20. 2010
  9. pmc Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sick
    Ernst R Schwarz
    Division of Cardiology, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Suite 6215, Los Angeles, CA 90048, USA
    J Relig Health 50:872-9. 2011
  10. doi request reprint Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart
    Ernst R Schwarz
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Cardiovasc Pharmacol Ther 14:215-21. 2009

Collaborators

Detail Information

Publications44

  1. ncbi request reprint A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both?
    Ernst R Schwarz
    Division of Cardiology, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Cardiovasc Pharmacol Ther 11:232-44. 2006
    ..Its potential role as adjunctive therapy in the treatment of heart failure as derived from experimental studies and clinical trials is discussed...
  2. pmc Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy
    R P Morrissey
    Division of Cardiology, Department of Medicine, Cedars Sinai Medical Centre and David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    Cardiovasc J Afr 22:38-44. 2011
    ..Therefore patients with known Fabry's disease should be screened early for cardiac involvement, as treatment benefit may not be seen once cardiac fibrosis has developed...
  3. pmc The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
    Jeremy A Falk
    Cedars Sinai Women s Guild Lung Institute, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Vasc Health Risk Manag 6:273-80. 2010
    ..In May 2009, the FDA approved tadalafil, the first once-daily PDE5 inhibitor for PAH. This review will outline the currently available data on tadalafil and its effects in patients with PAH...
  4. pmc Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men
    Ernst R Schwarz
    Cenegenics Education and Research Foundation, Las Vegas and Heart Institute of Southern California, Beverly Hills, 348 S Oakhurst Dr, Beverly Hills, CA 90212, USA
    J Geriatr Cardiol 8:201-6. 2011
    ..Partial androgen deficiency syndrome in the aging male is associated with signs of aging such as a development of abdominal obesity, sexual dysfunction, increase body fat, weight gain and the development of cardiac disease...
  5. pmc Andropause and the development of cardiovascular disease presentation-more than an epi-phenomenon
    Ernst R Schwarz
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Suite 6215, Los Angeles, CA 90048, USA Cenegenics Medical Institute, 851 Rampart Blvd, Las Vegas, NV 89145, USA
    J Geriatr Cardiol 8:35-43. 2011
    ....
  6. doi request reprint Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension
    Dioma U Udeoji
    Heart Institute of Southern California, Beverly Hills, Los Angeles, CA, USA
    Ther Adv Respir Dis 7:39-49. 2013
    ..Tadalafil in combination therapy seems to be additive and synergistic in relaxing pulmonary vascular muscle cells but more clinical trials on human subjects are warranted...
  7. doi request reprint Pilot study of palliative care consultation in patients with advanced heart failure referred for cardiac transplantation
    Ernst R Schwarz
    Cedars Sinai Heart Institute and Palliative Care Program, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Palliat Med 15:12-5. 2012
    ....
  8. pmc The clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure
    E R Schwarz
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center and University of California Los Angeles UCLA, Los Angeles, California, USA
    Cardiovasc J Afr 21:212-20. 2010
    ..Treatment recommendations for diastolic heart failure are primarily targeted at risk reduction and symptom relief. Currently, few data only are reported on diastolic dysfunction and its progression to systolic heart failure...
  9. pmc Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sick
    Ernst R Schwarz
    Division of Cardiology, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Suite 6215, Los Angeles, CA 90048, USA
    J Relig Health 50:872-9. 2011
    ..This article reflects on the multitude of critical issues that health care providers have to face while caring for patients with end-stage heart failure...
  10. doi request reprint Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart
    Ernst R Schwarz
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Cardiovasc Pharmacol Ther 14:215-21. 2009
    ..Early studies in different stress models have shown potential beneficial effects of exogenous zinc application with reduction in the rate of apoptotic cell death. This has not been shown in models of myocardial infarction...
  11. doi request reprint Philosophical implications of the systemic and patient-oriented management of chronic heart failure
    Ernst R Schwarz
    Cedars Sinai Heart Institute, Division of Cardiology, Cedar Sinai Medical Center, 8700 Beverly Blvd, Suite 6215, Los Angeles, CA 90048, USA
    J Relig Health 50:348-58. 2011
    ....
  12. ncbi request reprint Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure
    Ernst R Schwarz
    Division of Cardiology, Cedars Sinai Medical Center and University of California Los Angeles, Los Angeles, California 90048, USA
    J Cardiovasc Pharmacol Ther 12:232-6. 2007
    ....
  13. ncbi request reprint Erectile dysfunction in heart failure patients
    Ernst R Schwarz
    Division of Cardiology, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Am Coll Cardiol 48:1111-9. 2006
    ..This may, in turn, lead to noncompliance in misguided efforts to retain satisfactory sexual activity, with secondary worsening of cardiac capacity. This review describes the unique aspects of ED in the HF population...
  14. doi request reprint Religion and the Catholic church's view on (heart) transplantation: a recent statement of Pope Benedict XVI and its practical impact
    Ernst R Schwarz
    Division of Cardiology, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    J Relig Health 50:564-74. 2011
    ..The supportive role of the Roman Catholic Church and the recent statement of Pope Benedict XVI on organ donation are discussed...
  15. ncbi request reprint The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure
    E R Schwarz
    Division of Cardiology, Department of Medicine, Cedars Sinai Medical Center and University of California Los Angeles UCLA, Los Angeles, CA 90048, USA
    Int J Impot Res 20:85-91. 2008
    ..Despite the fact that most patients are interested in receiving therapy to improve sexual dysfunction, treatment options are rarely discussed or initiated...
  16. doi request reprint Use of ventricular assist device as bridge to simultaneous heart and kidney transplantation in patients with cardiac and renal failure
    R Yanagida
    Division of Cardiothoracic Surgery, Cedars Sinai Heart Institute, Los Angeles, California 90048, USA
    Transplant Proc 45:2378-83. 2013
    ..We present our experience with 6 patients who had combined heart and kidney transplantation (HKT) after VAD implantation for advanced cardiac and renal failure...
  17. ncbi request reprint A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients
    E R Schwarz
    Division of Cardiology, Department of Internal Medicine, The University of Texas Medical Branch UTMB, Galveston, 77555, USA
    Int J Impot Res 17:S37-43. 2005
    ..This article describes our experience with this unique patient population, as well as our approach to building a multidisciplinary clinic designed to specifically address the important issue of ED in the cardiac patient...
  18. doi request reprint Survival and allograft rejection rates after combined heart and kidney transplantation in comparison with heart transplantation alone
    L S C Czer
    Division of Cardiology, Cedars Sinai Heart Institute, Los Angeles, California 90048, USA
    Transplant Proc 43:3869-76. 2011
    ..We compared our experience with combined heart-kidney transplantation (HKT) and heart transplant alone (HT), and assessed patient survival rates and freedom from allograft rejection in these two patient groups...
  19. ncbi request reprint The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems
    E R Schwarz
    Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Int J Impot Res 19:139-48. 2007
    ..Only little data exist about long-term use of PDE-5i and their effects on different organ system. This paper reviews the current information available on chronic PDE-5 inhibitor use...
  20. ncbi request reprint Sex and the heart
    E R Schwarz
    Division of Cardiology, Department of Internal Medicine, The University of Texas Medical Branch UTMB, Galveston, 77555, USA
    Int J Impot Res 17:S4-6. 2005
    ..After careful evaluation, most patients with stable cardiac disorders can resume sexual activity and/or can be treated for ED...
  21. doi request reprint Heart transplantation in patients aged 70 years and older: a two-decade experience
    D Daneshvar
    Division of Cardiology, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, United States
    Transplant Proc 43:3851-6. 2011
    ..We analyzed the outcome of OHT in patients who were aged 70 years or older and compared the results with those in younger patients during a two-decade period...
  22. ncbi request reprint Reconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure
    R P Morrissey
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, and David Geffen School of Medicine, University of California Los Angeles UCLA, CA, USA
    Cardiovasc J Afr 21:158-63. 2010
    ..Diagnosis allows for early initiation of corticosteroids. Cardiac sarcoidosis is more common than previously thought. However, with treatment, survival may also be better than previously reported...
  23. doi request reprint Heart allograft transplanted twice
    Sinan A Simsir
    Division of Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Eur J Cardiothorac Surg 34:918-9. 2008
    ..We present the case of a man who underwent successful heart transplantation with an allograft that was obtained from a donor who had already received heart transplantation...
  24. doi request reprint Myocardial bridging in absence of coronary artery disease: proposal of a new classification based on clinical-angiographic data and long-term follow-up
    Ernst R Schwarz
    Division of Cardiology, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Cardiology 112:13-21. 2009
    ..There is no widely accepted classification to guide therapy in patients with symptomatic myocardial bridging (MB)...
  25. doi request reprint Heart transplantation using bivalirudin as anticoagulant
    Sinan A Simsir
    Division of Cardiothoracic Surgery, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Interact Cardiovasc Thorac Surg 10:150-1. 2010
    ..We present the case of a man with heparin-induced thrombocytopenia (HIT) and acute idiopathic decompensated cardiomyopathy who underwent successful heart transplantation with the use of bivalirudin as anticoagulant...
  26. ncbi request reprint Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem
    S Rastogi
    Department of Internal Medicine, Division of Cardiology, The University of Texas Medical Branch UTMB, Galveston, 77555, USA
    Int J Impot Res 17:S25-36. 2005
    ..This review describes contributing factors to ED in the setting of HF and highlights treatment considerations for this distinct patient population...
  27. doi request reprint Successful combined heart-bilateral lung-kidney transplantation from a same donor to treat severe hypertrophic cardiomyopathy with secondary pulmonary hypertension and renal failure: case report and review of the literature
    R K Rana
    Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Transplant Proc 43:2820-6. 2011
    ..We propose that a combined heart-lung-kidney transplantation may be an acceptable therapeutic option for carefully selected patients with advanced, concomitant cardiac, pulmonary, and kidney disease...
  28. doi request reprint Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates
    Sorel Goland
    Division of Cardiology, Cedars Sinai Medical Center, University of California, Los Angeles School of Medicine, Los Angeles, CA 90048, USA
    J Heart Lung Transplant 27:1115-21. 2008
    ..This retrospective single-center study compared lymphocyte depletion in 144 heart transplant recipients using 2 different induction protocols with Thymoglobulin (Genzyme Transplant, Cambridge, MA)...
  29. ncbi request reprint Amiodarone-induced QT prolongation in a newly transplanted heart associated with recurrent ventricular fibrillation
    E R Schwarz
    Cedars Sinai Heart Institute, Division of Cardiology, Division of Cardiothoracic Surgery, Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, and University of California Los Angeles, UCLA, Los Angeles, USA
    Cardiovasc J Afr 21:109-12. 2010
    ..Amiodarone, given to a recipient, might cause QT prolongation in a donor heart after transplantation, possibly due to its long half-life and increased bioavailability caused by interaction with immunosuppressive drugs...
  30. doi request reprint The first year post-heart transplantation: use of immunosuppressive drugs and early complications
    Nasir Z Sulemanjee
    Division of Cardiology, Department of Internal Medicine, The University of Texas Medical Branch, Galveston, TX, USA
    J Cardiovasc Pharmacol Ther 13:13-31. 2008
    ....
  31. ncbi request reprint The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease
    Vishal Kapur
    Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, California, USA
    Rev Cardiovasc Med 9:187-95. 2008
    ..In vivo and in vitro studies are examining the possible beneficial effects of PDE-5 inhibitors in conditions such as myocardial infarction and endothelial dysfunction...
  32. doi request reprint How does the heart (not) die? The role of autophagy in cardiomyocyte homeostasis and cell death
    Pavittarpaul Dhesi
    Division of Cardiology, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 6215, Los Angeles, CA 90048, USA
    Heart Fail Rev 15:15-21. 2010
    ....
  33. ncbi request reprint Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction
    Faramarz Tehrani
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Am J Cardiol 103:829-33. 2009
    ..32). In conclusion, based on the present data, it appears that use of certain common cardiac medications may not be associated with a significant effect on long-term survival in octogenarians with HF and preserved EF...
  34. ncbi request reprint Acute cellular transplant rejection following laparoscopic adjustable gastric banding in a morbidly obese patient post heart transplantation
    Shebna Unes Kunju
    Division of Cardiology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 6215, Los Angeles, CA 90048, USA
    J Cardiovasc Med (Hagerstown) 11:695-9. 2010
    ..However, this has not been frequently performed in organ-transplant recipients...
  35. doi request reprint Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome
    Barry F Uretsky
    Division of Cardiology, University of Texas Medical Branch at Galveston, Texas, USA
    Catheter Cardiovasc Interv 72:488-97. 2008
    ..The present study tested the hypothesis that intracoronary (IC) propranolol improves clinical outcomes with percutaneous coronary intervention (PCI) when used with background Gp IIb/IIIa receptor blockade...
  36. ncbi request reprint Linking erectile dysfunction and coronary artery disease
    J J Rodriguez
    Division of Cardiology, The University of Texas Medical Branch, Galveston, 77555, USA
    Int J Impot Res 17:S12-8. 2005
    ..This article reviews the role of vascular endothelium in health, the abnormalities resulting from vascular risk factors, and clinical trials evaluating the role of endothelial dysfunction in ED...
  37. ncbi request reprint Update on the safety of testosterone therapy in cardiac disease
    Alistair J Aaronson
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Suite 6215, Los Angeles, CA 90048, USA
    Expert Opin Drug Saf 10:697-704. 2011
    ..g., to improve athletic performance...
  38. pmc The prognostic value of anemia in patients with diastolic heart failure
    Faramarz Tehrani
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Tex Heart Inst J 36:220-5. 2009
    ..018).We found that anemia is associated with increased long-term mortality rates in patients who have diastolic heart failure. In addition, anemia appears to be an independent predictor of worse outcomes in elderly heart-failure patients...
  39. pmc Vineberg procedure for inadvertent injury to anomalous left anterior descending artery during tetralogy of fallot repair: four decades later
    Rajiv Gupta
    Division of Cardiology, University of Texas Medical Branch, Galveston, Texas 77555 0553, USA
    Tex Heart Inst J 33:98-9. 2006
  40. doi request reprint Clinical Review: Is the perioperative use of beta-blockers still recommended? A critical review of recent controversies
    Damian Domanski
    Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Cardiovasc Pharmacol Ther 14:258-68. 2009
    ..Based on the observations from different studies, we propose an algorithm for perioperative beta blockade...
  41. ncbi request reprint Impact of obesity in patients with congestive heart failure
    Shebna Unes Kunju
    Cedars Sinai Heart Institute, Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Rev Cardiovasc Med 10:142-51. 2009
    ....
  42. ncbi request reprint Left main coronary artery thrombus: a case series with different outcomes
    Rajiv Gupta
    Division of Cardiology, Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 77555 0553, USA
    J Thromb Thrombolysis 19:125-31. 2005
    ..We describe our experience with six patients who presented with LMCA thrombosis and discuss the epidemiology, etiology and management options available for this high-risk subgroup...
  43. ncbi request reprint An agonist of liver X receptor slows valvular disease in a hypercholesterolemia mouse model
    Haimei Wang
    Division of Cardiothoracic Surgery, Department of Surgery, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Blvd, Davis Building Room 6014, Los Angeles, California 90048, USA
    J Heart Valve Dis 19:653-64. 2010
    ..It was hypothesized that an LXR agonist would reduce calcium and lipid deposition in aortic valves...
  44. doi request reprint The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation
    Keith A Thompson
    Department of Medicine, Division of Cardiology, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    J Cardiovasc Pharmacol Ther 15:231-43. 2010
    ....